Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

Circulation. 2001 Apr 17;103(15):1949-54. doi: 10.1161/01.cir.103.15.1949.

Abstract

Background: Carriers of the apolipoprotein A-I(Milano) (apoA-I(M)) mutant present with very low plasma HDL cholesterol and moderate hypertriglyceridemia, apparently not leading to premature coronary heart disease. The objective of this study was to establish whether this high-risk lipid/lipoprotein profile is associated with structural changes in the carotid arteries and heart, indicative of preclinical atherosclerosis.

Methods and results: Twenty-one A-I(M) carriers were compared with age- and sex-matched control subjects from the same kindred and with 2 series of matched subjects with primary hypoalphalipoproteinemia (HA). Structural changes in the carotid arteries were defined as the intima-media thickness (IMT) measured by B-mode ultrasound. HA subjects, both recruited among patients attending our Lipid Clinic and blood donors, showed significant thickening of the carotids (average IMT, 0.86+/-0.25 and 0.88+/-0.29 mm, respectively) compared with control subjects (average IMT, 0.64+/-0.12 mm); the apoA-I(M) carriers instead showed normal arterial thickness (average IMT, 0.63+/-0.10 mm). Moreover, a significantly higher prevalence of atherosclerotic plaques was found in patients and blood donors with HA (both 57%) compared with apoA-I(M) carriers (33%) and control subjects (21%). Echocardiographic findings and maximal treadmill ECG did not differ significantly between apoA-I(M) carriers and control subjects, apart from a slight increase in left ventricular end-diastolic dimension in the carriers.

Conclusions: Despite severe HA, carriers of the apoA-I(M) mutant do not show structural changes in the arteries and heart, in contrast to HA subjects, who are characterized by a marked increase in carotid IMT and increased prevalence of atherosclerotic plaques.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-I / blood
  • Apolipoprotein A-I / genetics*
  • Cardiac Output / genetics
  • Carotid Arteries / diagnostic imaging
  • Carotid Artery Diseases / blood
  • Carotid Artery Diseases / diagnosis*
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Cholesterol, VLDL / blood
  • Echocardiography
  • Electrocardiography
  • Exercise Test
  • Female
  • Heterozygote*
  • Humans
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / diagnosis
  • Hypertriglyceridemia / genetics*
  • Lipoproteins, HDL / blood
  • Lipoproteins, HDL / deficiency
  • Lipoproteins, HDL / genetics*
  • Male
  • Triglycerides / blood
  • Tunica Intima / diagnostic imaging
  • Tunica Media / diagnostic imaging

Substances

  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Cholesterol, VLDL
  • Lipoproteins, HDL
  • Triglycerides
  • apolipoprotein A-I Milano
  • Cholesterol